Ignite Creation Date:
2025-12-24 @ 7:22 PM
Ignite Modification Date:
2026-03-22 @ 1:36 PM
Study NCT ID:
NCT05375903
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-02-14
First Post:
2022-05-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)
Sponsor:
UroGen Pharma Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
UR001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None